Literature DB >> 18941324

Consider delayed immunosuppression into the concept of sepsis.

Joerg C Schefold, Dietrich Hasper, Petra Reinke, Guillaume Monneret, Hans-Dieter Volk.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18941324     DOI： 10.1097/CCM.0b013e31818bdd8f

Source DB:  PubMed          Journal:  Crit Care Med        ISSN： 0090-3493            Impact factor:   7.598


× No keyword cloud information.
  24 in total

1.  Measurement of monocytic HLA-DR (mHLA-DR) expression in patients with severe sepsis and septic shock: assessment of immune organ failure.

Authors:  Joerg C Schefold
Journal:  Intensive Care Med       Date:  2010-07-23       Impact factor: 17.440

2.  Life ain't no SOFA-considerations after yet another failed clinical sepsis trial.

Authors:  David Berger; Joerg C Schefold
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

3.  Immunosuppression in patients who die of sepsis and multiple organ failure.

Authors:  Jonathan S Boomer; Kathleen To; Kathy C Chang; Osamu Takasu; Dale F Osborne; Andrew H Walton; Traci L Bricker; Stephen D Jarman; Daniel Kreisel; Alexander S Krupnick; Anil Srivastava; Paul E Swanson; Jonathan M Green; Richard S Hotchkiss
Journal:  JAMA       Date:  2011-12-21       Impact factor: 56.272

4.  Reduced monocytic HLA-DR expression indicates immunosuppression in critically ill COVID-19 patients.

Authors:  Thibaud Spinetti; Cedric Hirzel; Michaela Fux; Laura N Walti; Patrick Schober; Frank Stueber; Markus M Luedi; Joerg C Schefold
Journal:  Anesth Analg       Date:  2020-06-04       Impact factor: 5.108

5.  High-mobility group box-1 protein serum levels do not reflect monocytic function in patients with sepsis-induced immunosuppression.

Authors:  Nadine Unterwalder; Christian Meisel; Konstantinos Savvatis; Ben Hammoud; Christina Fotopoulou; Hans-Dieter Volk; Petra Reinke; Joerg C Schefold
Journal:  Mediators Inflamm       Date:  2010-06-21       Impact factor: 4.711

6.  Role of biphasic changes in splenic dendritic cell activity in a mouse model of multiple organ dysfunction syndrome.

Authors:  Yi Lv; Qian Liu; Min Zhao; Yiduo Jin; Jiangyang Lu
Journal:  Int J Clin Exp Pathol       Date:  2014-07-15

7.  Intensive care unit-acquired weakness (ICUAW) and muscle wasting in critically ill patients with severe sepsis and septic shock.

Authors:  Joerg C Schefold; Jeffrey Bierbrauer; Steffen Weber-Carstens
Journal:  J Cachexia Sarcopenia Muscle       Date:  2010-12-17       Impact factor: 12.910

8.  Immunostimulation using granulocyte- and granulocyte-macrophage colony stimulating factor in patients with severe sepsis and septic shock.

Authors:  Joerg C Schefold
Journal:  Crit Care       Date:  2011-03-31       Impact factor: 9.097

Review 9.  Granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage colony stimulating factor (GM-CSF) for sepsis: a meta-analysis.

Authors:  Lulong Bo; Fei Wang; Jiali Zhu; Jinbao Li; Xiaoming Deng
Journal:  Crit Care       Date:  2011-02-10       Impact factor: 9.097

10.  Phenotype changes and impaired function of dendritic cell subsets in patients with sepsis: a prospective observational analysis.

Authors:  Holger Poehlmann; Joerg C Schefold; Heidrun Zuckermann-Becker; Hans-Dieter Volk; Christian Meisel
Journal:  Crit Care       Date:  2009-07-15       Impact factor: 9.097
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.